| Big data for open innovation in SMEs and large corporations: Trends, opportunities, and challenges P Del Vecchio, A Di Minin, AM Petruzzelli, U Panniello, S Pirri Creativity and Innovation Management 27 (1), 6-22, 2018 | 263 | 2018 |
| Rare diseases under different levels of economic analysis: current activities, challenges and perspectives S Cannizzo, V Lorenzoni, I Palla, S Pirri, I Triulzi, G Turchetti RMD open 4 (Suppl 1), e000794, 2018 | 44 | 2018 |
| Scoping review and bibliometric analysis of Big Data applications for Medication adherence: an explorative methodological study to enhance consistency in literature S Pirri, V Lorenzoni, G Turchetti BMC Health Services Research 20 (1), 1-23, 2020 | 39 | 2020 |
| Cost-Effectiveness of Direct Non-Vitamin K Oral Anticoagulants Versus Vitamin K Antagonists for the Management of Patients with Non-Valvular Atrial Fibrillation Based on … V Lorenzoni, S Pirri, G Turchetti Clinical Drug Investigation 41 (3), 255-267, 2021 | 15 | 2021 |
| RarERN Path: a methodology towards the optimisation of patients’ care pathways in rare and complex diseases developed within the European Reference Networks R Talarico, S Cannizzo, V Lorenzoni, D Marinello, I Palla, S Pirri, S Ticciati, ... Orphanet Journal of Rare Diseases 15 (1), 1-10, 2020 | 15 | 2020 |
| Topic Modeling and User Network Analysis on Twitter during World Lupus Awareness Day S Pirri, V Lorenzoni, G Andreozzi, M Mosca, G Turchetti International Journal of Environmental Research and Public Health 17 (15), 5440, 2020 | 11 | 2020 |
| Expert opinion and patients’ in-depth interviews on the impact of pulmonary complications in systemic sclerosis A Caminati, B Vigone, S Cozzaglio, P De Nigris, I Galetti, S Nunzio, ... Current Medical Research and Opinion 37 (sup2), 17-26, 2021 | 7 | 2021 |
| Adherence to treatment in Behçet’s syndrome: a multi-faceted issue S Pirri, D Marinello, V Lorenzoni, G Andreozzi, A Bazzani, A Del Bianco, ... Clinical and experimental rheumatology 39 (5), S88-S93, 2021 | 4 | 2021 |
| A systematic literature review of existing tools used to assess medication adherence in connective tissue diseases: the state of the art for the future development of co … S Pirri, R Talarico, D Marinello, G Turchetti, M Mosca Reumatismo 73 (3), 2021 | 2 | 2021 |
| One year in review 2020: economic and organisational aspects in rare and complex connective tissue diseases S Cannizzo, I Palla, S Pirri, I Triulzi, C Carta, D Taruscio, G Turchetti Clin Exp Rheumatol 38 (6), 1037-45, 2020 | 2 | 2020 |
| Exploring disease perception in Behçet’s syndrome: combining a quantitative and a qualitative study based on a narrative medicine approach D Marinello, I Palla, V Lorenzoni, G Andreozzi, S Pirri, S Ticciati, ... Orphanet Journal of Rare Diseases 18 (1), 1-15, 2023 | 1 | 2023 |
| What are the characteristics of a resilient healthcare system: A Scoping Review SG Emami, V Lorenzoni, S Pirri, G Turchetti | 1 | 2023 |
| How Italy Tweeted about COVID-19: Detecting Reactions to the Pandemic from Social Media V Lorenzoni, G Andreozzi, A Bazzani, V Casigliani, S Pirri, L Tavoschi, ... International Journal of Environmental Research and Public Health 19 (13), 7785, 2022 | 1 | 2022 |
| Patient-reported Outcome Measures in Systemic Lupus Erythematosus: Use in Clinical Practice-Preliminary Results from the Integrate Project G Chehab, J Richter, A Kernder, C Tani, V Lorenzoni, E Elefante, I Palla, ... ARTHRITIS & RHEUMATOLOGY 71, 2019 | 1 | 2019 |
| The Application Of Big Data Analysis To Measure And Better Understand Medication Adherence: A Systematic Literature Review S Pirri, G Turchetti Value in Health 20 (9), A680, 2017 | 1 | 2017 |
| Correction to: RarERN Path: a methodology towards the optimisation of patients’ care pathways in rare and complex diseases developed within the European Reference Networks R Talarico, S Cannizzo, V Lorenzoni, D Marinello, I Palla, S Pirri, S Ticciati, ... Orphanet Journal of Rare Diseases 16 (1), 1-1, 2021 | | 2021 |
| RarERN Path: a methodology towards the optimisation of patients' care pathways in rare and complex diseases developed within the European Reference Networks (vol 15, 347, 2020) R Talarico, S Cannizzo, V Lorenzoni, D Marinello, I Palla, S Pirri, S Ticciati, ... ORPHANET JOURNAL OF RARE DISEASES 16 (1), 2021 | | 2021 |
| RarERN Path: a methodology towards the optimisation of patients’ care pathways in rare and complex diseases developed within the European Reference Networks T Rosaria, C Sara, L Valentina, M Diana, P Ilaria, P Salvatore, T Simone, ... Orphanet Journal of Rare Diseases 15 (1), 1-10, 2020 | | 2020 |
| La reazione dell’Italia di fronte alla pandemia di COVID-19 attraverso l’analisi dei dati provenienti da social media V Lorenzoni, G Andreozzi, A Bazzani, C Virginia, S Pirri, T Lara, ... L’epidemiologia per l’epidemia: la strada per la sanità post COVID. XLIV …, 2020 | | 2020 |
| PMU138 EXPLORATIVE SCOPING REVIEW AND BIBLIOMETRIC ANALYSIS OF BIG DATA APPLICATIONS FOR MEDICATION ADHERENCE S Pirri, C Pagliari, V Lorenzoni, G Turchetti Value in Health 22, S732-S733, 2019 | | 2019 |
Giuseppe TurchettiScuola Superiore Sant'AnnaVerified email at sssup.it
